CAS: 912287-56-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | YHO-13177 REF: AN-AG00GU9MCAS: 912287-56-0 | 98+% | 177,00 €~543,00 € | Lun 15 Jul 24 |
 | YHO-13177 REF: TM-T4595CAS: 912287-56-0 | 98.64% | 39,00 €~505,00 € | Lun 22 Jul 24 |
 | YHO-13177 REF: 3D-MLB28756CAS: 912287-56-0 | Min. 95% | A consultar | Lun 26 Ago 24 |
Ref: AN-AG00GU9M
| 1g | 543,00 € | ||
| 100mg | 177,00 € | ||
| 250mg | 215,00 € |
Entrega estimada en Estados Unidos, el Lunes 15 de Julio de 2024
YHO-13177
CAS:912287-56-0
YHO-13177 is a potent and specific inhibitor of BCRP; potentiated the cytotoxicity of SN-38 in …
Fórmula:
C20H22N2O3S
Pureza:
98.64%
Forma y color:
Solid
Peso molecular:
370.47
Ref: TM-T4595
| 1mg | 39,00 € | ||
| 1ml | 92,00 € | ||
| 5mg | 82,00 € | ||
| 10mg | 110,00 € | ||
| 25mg | 212,00 € | ||
| 50mg | 317,00 € | ||
| 100mg | 505,00 € |
Entrega estimada en Estados Unidos, el Lunes 22 de Julio de 2024
YHO-13177
CAS:912287-56-0
YHO-13177 is a novel chemotherapeutic drug that is being investigated for its effectiveness against cancer. …
Fórmula:
C20H22N2O3S
Pureza:
Min. 95%
Peso molecular:
370.47 g/mol
Ref: 3D-MLB28756
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 26 de Agosto de 2024
